NEW YORK (GenomeWeb News) – Entelos and the Institute for Systems Biology today announced a partnership that led to the integration of gene expression data into quantitative physiological simulations.

The new capability, they added, "improves understanding of the gene expression and disease outcome to radically improve the predictive discernment of the complex nature of disease." As a result, new insights into therapeutic targets, biomarkers, and patient selection can be gained.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.